THE SUPERNOVA STUDY
For some people, COVID-19 might seem like the distant past. But for those with a weakened immune system, the threat of the virus is still present. AstraZeneca is researching a trial drug that could help protect against new strains of SARS-CoV-2. The SUPERNOVA trial’s aim is to develop a medication that protects people with weaker immune systems from getting seriously ill from COVID-19.
SUPERNOVA trial eligibility criteria:
- This study is looking at an investigational medication (study drug) to see if it is safe and can help to protect people with an impaired immune system from contracting COVID-19.
- You, or someone you care for, may be able to take part if you/they:
- are 12 years of age or older and have an impaired immune system
- have not tested positive for COVID-19 or received a COVID-19 vaccine in the past 3 months
- weigh at least 40 kg
- To learn more and the SUPERNOVA clinical trial, the link to the website can be found here.
- FAQs about the trial can be found here.
- The AZ information center (1-800-236-9933) is prepared to take calls with questions about the SUPERNOVA site.
Click to view the
